KCNK2 and migraine disorder: We induced and evaluated cutaneous allodynia, a quantifiable marker of migraine, after four consecutive days of ISDN injections in wild-type and Trek1−/−-Trek2−/− mice by measuring paw withdrawal mechanical threshold using a dynamic von Frey esthesiometer before each injection (Figure 1A).